ruptured heart repaired through complex, two

Summer 2013
Vol. 27, No. 2
MESSAGE FROM THE PRESIDENT
Welcome to the
summer issue of
Rounds. In this
issue, we recognize
the truly exciting
events and
accomplishments at
Henry Ford Hospital,
including news
from the Center
for Structural Heart Lawrence Mitchell, M.D.
Disease and the
achievements of our
graduating residents.
At the Center for Structural Heart Disease,
we welcomed William W. O’Neill, M.D.,
as its medical director. One of the reasons
why Dr. O’Neill was glad to join Henry
Ford is our commitment to technological
innovations. In this issue, you can read
about the successful repair of a ruptured
heart and the opening of five blocked
blood vessels, a procedure that was led by
Drs. O’Neill and Adam Greenbaum. This
complex, minimally invasive procedure
is one of the innovations that Dr. O’Neill
has pioneered throughout his medical
career.
We also celebrate the achievements of
our graduating residents and fellows.
You will find a list of graduates as well
as the nominees and recipients of the
Outstanding Resident Awards. This
(Continued on Page 7)
What’s Inside
Research Spotlight - Page 2
Atrial Fibrillation Center - Page 3
Investigating Stem Cells - Page 4
In Memoriam - Page 6
Alumni Notes - Page 8
Outstanding Resident Awards
and 2013 Graduate List - Pages 9-11
For members of the Henry Ford Medical Association,
Henry Ford Physicians, Residents and Alumni
RUPTURED HEART REPAIRED THROUGH COMPLEX,
TWO-STAGE CATHETERIZATION PROCEDURE
A team of doctors at Henry Ford Hospital
successfully repaired a hole in the heart
and opened five blocked blood vessels
in a complex, two-stage catheterization
procedure.
The initial March 13, 2013 procedure used
the Impella CP, a left ventricular assist
device, to stabilize the patient and allowed
the hole in the heart’s ventricle (lower
chamber) to be closed.
Retired plant engineer Joseph Mehal, 84,
hadn’t been feeling well for more than a
week. He had no appetite and thought he
might have the flu, but he had no chest
pain or other classic symptoms to indicate
a possible heart attack.
An emergency department physician
diagnosed a heart attack, and Mehal was
rushed to the cardiac catheterization lab.
The team was led by Drs. William O’Neill
and Adam Greenbaum of the Center for
Structural Heart Disease at Henry Ford
Hospital.
“The Impella CP device was essential
in allowing us to enter the heart and
successfully close the defect, and it kept
the patient alive while catheters were in his
heart,” says Dr. Greenbaum.
Once the hole was closed, the patient
returned to the cath lab 36 hours later and
had complex stent therapy to open five
blocked blood vessels.
“Closing the hole in the ventricle and
high-risk angioplasty have been performed
successfully before, but never together in
one patient who was in cardiogenic shock,”
says Dr. O’Neill.
Mehal recuperated in the hospital and his
doctors are optimistic that he will return to
normal activity.
Adam Greenbaum, M.D. (left) and
William W. O’Neill, M.D.
“My liver and kidneys were failing,” says
Mehal. “Thanks to fast action and expertise,
not only was my life saved, but my kidneys
have recovered. My nephrologist said I was
one day away from needing dialysis.”
Dr. O’Neill is an internationally recognized
cardiologist, who was a pioneer in the
use of angioplasty for treatment of heart
attacks, now the primary therapy used
throughout the world. He is the architect
of non-invasive heart surgery, performing
the first heart valve replacement through a
catheter in North America in 2005.
A long list of his career accomplishments
includes:
• First in the U.S. to use a heart-cooling
procedure to reduce heart-attack damage.
Lowering body temperature up to 9
degrees Fahrenheit through a chilled IV
solution has shown promising results in
protecting a patient from brain damage
after a heart stops.
• First in the U.S. to use stem-cell therapy
for heart repair.
(Continued on Page 7)
RESEARCH SPOTLIGHT
$12.4 MILLION NIH GRANT FUNDS
HYPERTENSION RESEARCH
A senior staff scientist and his
team at Henry Ford Hospital have
been awarded a five-year, $12.4
million grant by the National
Institutes of Health for their
research into the damaging effects
of high blood pressure on various
organs in the body.
Hypertension is a major public
health issue in the United States,
with an estimated 75 million
Americans with the disease. It
can also contribute to other major
health problems such as heart
attack and stroke.
Oscar A. Carretero, M.D., of Henry
Ford’s Hypertension and Vascular
Research Division, is investigating
how autacoids, which are small
molecules and hormones produced
by various cells in the body,
regulate kidney function and blood
pressure, leading to hypertension
and tissue and organ damage.
Although these biological
substances and hormones
generally affect cells next to or
near where they are secreted,
they can be transported through
the bloodstream. Dr. Carretero’s
research is investigating how,
when this happens, they can
damage distant tissue and organs.
In particular, the various projects
are examining the mechanisms
by which various autacoids
either exacerbate or reduce the
pro-hypertensive effects of the
hormone angiotensin II.
“I am very proud and grateful to
my research team,” Dr. Carretero
said when he learned of the
award. “This project took a lot of
teamwork and all of the members
deserve credit. They worked very
hard under a lot of pressure to
make this grant possible.”
The NIH grant will provide
$2,472,318 each year for five years
to fund four related projects. Dr.
Carretero, who is the principal
investigator, also heads two of the
projects.
Besides Dr. Carretero, key among
the 18 people involved in the
scientific and administrative
Oscar A. Carretero, M.D.
functions of the grant are Henry
Ford’s Pamela Harding, Ph.D.; Jeff
Garvin, Ph.D.; Xiao-Ping Yang,
M.D.; Ed Shesely, Ph.D.; and Ed
Peterson, Ph.D.
This research proposal began
in 1982 and will now continue
through the end of January 2018,
continuing NIH funding for 35
years. 
CME OPPORTUNITIES
SEPT.
16-18
The Detroit Institute of Ophthalmology is hosting the 2013 The Eye, the Brain &
the Auto research congress Sept. 16-18, 2013 at The Henry in Dearborn, Mich.
OCT.
26
Henry Ford Heart & Vascular Institute is hosting a continuing medical education
Conference Saturday, October 26, 2013 at the Atheneum Hotel - Detroit.
NOV.
15
The Josephine Ford Cancer Institute and the Henry Ford Department of
Dermatology are hosting the 2nd Melanoma Symposium Friday, November 15,
2013 at the Detroit Marriott.
For more information about these and other CME opportunities, visit henryford.com/cme
2
ATRIAL FIBRILLATION CENTER
Head off complications with a single phone call
With a single phone call, physicians
who suspect atrial fibrillation can
schedule an immediate outpatient
appointment for diagnosis, treatment
and condition management. The
Atrial Fibrillation Center, established
in summer 2012, is accepting patients
from referring physicians.
“Atrial fibrillation is one of the most
interesting, puzzling public health
problems in the western world,”
says Claudio Schuger, M.D., director,
Cardiac Electrophysiology. “Today, it
affects 3.5 million Americans, but by
2050, a projected 12 million or more
will be affected. Atrial fibrillation
accounts for 15 to 20 percent of
strokes in the U.S., and in patients
with an uncontrolled rapid heart rate,
there is an increased risk of heart
failure due to weakening of the heart
muscle. It is pertinent to address
and understand the dynamics of the
condition.”
The Center’s four senior
electrophysiologists and three
dedicated nurse practitioners
are experts in managing rhythm
abnormalities. They provide accurate
and quick diagnosis and a holistic
approach to the management of atrial
fibrillation and the prevention of
potentially devastating complications.
While atrial fibrillation is only an
electrocardiographic manifestation,
its etiology may be multi-factorial,
adding to disease complexity.
“Some patients are symptomatic,
others are not, and time between
detection of abnormalities and
referral is valuable. We see patients
in different moments in their
history of the disease, from origin
to long-term complications,” says
Dr. Schuger.
Treatment options include:
Rhythm control: Catheter ablation
continues to grow and evolve
as a strategy to suppress atrial
fibrillation, particularly for those
patients unresponsive or intolerant
of standard medical therapy. To
investigate this technique, Henry
Ford Hospital is now participating
in the international CABANA
trial to study the efficacy of
AF ablation. In addition, Henry
Ford currently utilizes the most
up-to-date technologies for this
procedure, including:
• 3-D anatomic mapping using the
CARTO-3 and CARTO-SOUND
mapping systems
• Remote magnetic navigation (Stereotaxis)
Claudio Schuger, M.D.
• Cryoballoon technology
Stroke Prevention: Regardless
of whether rhythm control is
attempted, patients with AF may
be at increased risk for stroke. For
those unable to take traditional
anticoagulant medications, Henry
Ford provides a variety of both
FDA-approved and investigational
invasive procedures aimed at
stroke prevention. These modalities
include:
• The LARIAT epicardial left atrial
appendage suture device
• The Watchman device, recently
approved to endocardially isolate
the left atrial appendage
(Continued on Page 5)
A 3-D reconstruction of the left atrium
and pulmonary veins with ablation lesions
(red) delivered circumferentially around the
antrum of the veins. This electrically isolates
the pulmonary veins from the left atrium,
which is responsible for the initiation of
atrial fibrillation in most cases.
3
INVESTIGATING STEM CELLS TO PRESERVE HEART FUNCTION
Retired science teacher and former
principal of Cass Tech High School
Lenora Ashford, 64, of Detroit, was
recovering from a heart attack at
Henry Ford Hospital, when her
cardiologist asked if she would
like to be part of a new national
research study. He felt she could be
a candidate to participate in a study
to investigate treating a recent heart
attack with a patient’s own stem cells
to preserve heart muscle function.
Henry Ford is the first hospital
in Michigan to participate in the
PreSERVE AMI Phase II research
study, for adults who have received
a stent to open a blocked artery after
an acute heart attack, who also meet
other criteria.
“As a teacher, I always encouraged
my students to participate in science
projects,” says Ashford. “Now I
could become part of a science
project. It was an opportunity to
practice what I preached, and I felt it
would be beneficial.”
It was determined that Ashford
was qualified to participate in
the study, which has very strict
entry criteria for patients. She
had marrow harvested from her
hip bone to isolate her own stem
cells for the procedure. Two days
later, following the rules of the
study, either the processed stem
cells or a placebo were infused
through a catheter in the coronary
artery to the area of damaged heart
muscle. Both the harvesting and the
infusion of stem cells are outpatient
procedures.
“You don’t make progress unless
you take chances,” says Ashford. “I
have a lot of family members in the
medical field and I discussed it with
them. They were very supportive,
and I thought, why not? Now, I feel
so much better. Would I do it again?
Absolutely.”
“Stem cell therapy offers new
potential approaches in the treatment
of acute heart attack patients to
Gerald Koenig, M.D., Ph.D.
prevent further damage to heart
muscle and improve function,”
says Gerald Koenig, M.D., Ph.D., a
cardiologist and researcher at Henry
Ford. “Current standard treatment
options only limit the weakening of
the heart. This is why we
are studying stem cell
therapy, which looks very
promising, but it is still
an investigation, not an
established treatment.”
The body has a way to
repair itself. When a heart
attack occurs, the heart
sends a distress signal
to the body, which then
sends repair cells to the
injury site. In some cases,
depending on the severity
of damage, the repair is
insufficient, with a poor
prognosis for the patient.
A dead zone of tissue
develops in the heart,
while the surrounding
healthy heart cells are
stressed as they work
harder to pump blood.
(Continued on next page)
4
The American Heart Association, with
the assistance of the National Institutes
of Health, reports that an average of 16
years of life may be lost due to a heart
attack.
“Previous studies using adult stem
cells to limit heart muscle damage
and improve function have had mixed
success,” says Dr. Koenig. “Some
studies have tried to do this too soon
after a heart attack, and some tried the
procedure at a later time.
“It has been determined that there’s a
window of opportunity - one week to
10 days after a heart attack - which is
the most effective time for stem cell
treatment.”
The type of stem cell used to treat
heart muscle is critical for success,
according to Dr. Koenig, as well as
the number of cells infused. When
the correct amount of the right cells
are used in the specified timeframe,
the possibility of preserving heart
function is much higher.
“We look for a specific stem
cell that has the capability to
improve the function of the heart,
potentially by regenerating tissue,
or as in this case, preventing the
loss of heart muscle that typically
continues for weeks after the heart
attack,” he says.
“An acute heart attack can severely
weaken heart muscle. Today’s
therapies, including balloon
angioplasty and stents to reopen
blocked blood vessels, and
medication, have raised the survival
rate for patients. However, one
third of heart attack survivors has a
significant amount of damage to the
heart, and is at high risk to develop
congestive heart failure over several
years.” 
For more information on the
PreSERVE AMI Phase II study,
please call (313) 916-1879.
ATRIAL FIBRILLATION CENTER (Continued from Page 3)
• The Amplatzer Cardiac Plug (ACP),
currently being investigated in a
nationwide study for endocardial
left atrial appendage isolation
“We work to prevent the
complications that can result from
atrial fibrillation,” says Dr. Schuger.
“Thromboembolism prevention is
achieved mainly by new or traditional
anticoagulation agents. Invasive
alternatives for patients with strict
contraindications for anticoagulation
are based in left atrial appendage
occlusion strategies such as
percutaneous epicardial ligations
(LARIAT) or endocardial left atrial
appendage closures (Amplatzer).”
The Atrial Fibrillation Center
staff will also create a database
for use in future quality initiative
proposals and development of
effective treatment strategies for
specific cohorts.
When calling the hotline, referring
physicians will be asked to describe
the patient and provide the medical
record number, if available.
Referrals result in an immediately
scheduled outpatient appointment.
Inpatients may also be referred.
Referring physicians receive
ongoing communication
regarding diagnosis and condition
management of their patient. 
For more information or to refer a
patient, call the Atrial Fibrillation
hotline at (313) 916-AFIB (2342).
A 3-D reconstruction of the left atrium and
pulmonary veins, demonstrating placement
of a circular mapping catheter into the
Os of the pulmonary vein to help identify
pulmonary vein potentials. Elimination
of these potentials is part of the goal of the
procedure.
5
IN MEMORIAM
Peter B. Gram, M.D., a former
intern in the Department of
Orthopaedic Surgery at Henry Ford
Hospital, passed away on December
25, 2011. Following his training
at Henry Ford, Dr. Gram practiced
in Manchester, Conn. and taught
at the University of Connecticut
Medical School. During this time
he also practiced at the Newington
Children’s Hospital and then in
Hartford when the hospital was
relocated. Dr. Gram was regarded
as a man of many talents, and
he painted, sculpted, played the
guitar and spoke six languages
fluently. During his career, Dr. Gram
published many books about events
in his life and about his family. He
received his medical degree from the
University of Rochester, and prior to
beginning his education in America,
Dr. Gram served with the British
resistance forces and the Office
of Strategic Services (OSS) during
World War II. He is survived by his
wife of 62 years Marie, six children
and eight grandchildren.
Charles (Gene) Jackson, M.D.,
former head of the Third Medical
Division and chief of the Clinical
Genetics Division at Henry
Ford Hospital, passed away on
December 30, 2012. During his
career at Henry Ford, Dr. Jackson
6
worked as a physician, performed
extensive genetics research and
served on several National Institutes
of Health Study Sections. He was
devoted to researching many
diseases and conditions, including
muscular dystrophies, Alzheimer’s
disease and multiple endocrine
neoplasias. Dr. Jackson received
numerous awards and recognitions,
including the Henry Ford Medical
Association Distinguished Career
Award in 1997, and he published
more than 200 medical articles.
After retiring to Temple, Texas in
2001, Dr. Jackson continued his
genetics research and published more
than16 additional journal articles.
He fondly remembered his time at
Henry Ford and had a great love for
his colleagues and patients. Early
in his career, Dr. Jackson served
as a Major in the Army Reserves
and was stationed at Walter Reed
General Hospital in Washington,
D.C. He is survived by his son,
three grandchildren and two greatgrandchildren.
Gilbert D. Jay III, M.D., a former
General Surgery resident at Henry
Ford Hospital, passed away on
October 15, 2012 at the age of 92.
After completing his residency,
Dr. Jay entered private practice in
West Memphis, Ark. and was the
first surgeon to service the area. He
remained in practice for 35 years. In
1952, the West Memphis Chamber of
Commerce awarded him their Man of
the Year Award. Before finishing his
training at Henry Ford, Dr. Jay served
two years as a flight surgeon during
World War II. He is survived by his
beloved wife of 70 years Mary, four
children, seven grandchildren and
eight great-grandchildren.
Raymond C. Mellinger, M.D.,
former head of the Division of
Endocrinology, physician and
resident at Henry Ford Hospital,
passed away March 4, 2013 in
East Lansing, Mich. His career of
more than 40 years at Henry Ford
began in 1948 when he entered
his residency. Dr. Mellinger was
named head of the Division of
Endocrinology in 1966. During
his time at Henry Ford, Dr.
Mellinger was involved in the
Endocrine Fellowship Program,
and he impacted the education and
training of many young physicians
from around the world. He was
well known for his treatment and
extensive research of Cushing’s
syndrome. Dr. Mellinger was
author or co-author of more than
85 medical articles, and he also
served as the editor of the Henry
Ford Hospital Medical Journal for
10 years. During his residency,
Dr. Mellinger left for two years
to serve as a regimental surgeon
for the U.S. Army’s 35th Infantry
in Japan. He is survived by six
children, 13 grandchildren and
step-grandchildren and one greatgranddaughter.
Message from the President
(Continued from Front Page)
year, the awards banquet was held
May 15 at the Detroit Athletic
Club, and 25 residents and fellows
were honored for their dedication
to patient care, research and
education. Having been trained at
Henry Ford Hospital and serving
in the role of an educator, I am
very familiar with the excellence of
our programs (See Pages 9-11 for
a list of awardees, nominees and
graduates).
George R. Mikhail, M.D., a surgeon
at Henry Ford Hospital, passed away
on April 5, 2013. Dr. Mikhail’s career
at Henry Ford began in 1963, and he
worked to become a skilled expert
in the Mohs surgery technique. He
started the Mohs Surgery Clinic at
Henry Ford in 1967, which was one
of the first clinics in the country at
the time. Dr. Mikhail was a member
of many medical organizations, and
he held leadership positions in many
of these societies, such as president of
the Michigan Dermatological Society.
Dr. Mikhail published more than 70
medical publications and authored
two books on Mohs surgery. He was
acknowledged for his achievements
with various awards, including the
Distinguished Career Award from
Henry Ford Medical Association in
1980. Dr. Mikhail received his medical
degree from the Cairo School of
Medicine in Egypt. He is survived
by his wife Elizabeth and daughter
Marianne.
Kavitha Vanga, M.D., a Henry Ford
Medical Group physician, passed away
on April 4, 2013. Dr. Vanga’s medical
training began when she completed
her medical education and internship
at Osmania Medical College in India.
Following her education in India,
she did her residency at Grace
Hospital in Detroit. Dr. Vanga began
practicing medicine in 1999, and
she specialized in hepatology and
women’s health. Dr. Vanga worked
in the Department of Internal
Medicine at Henry Ford Medical
Center – Fairlane, where she was
highly respected and regarded by
her patients.
Frank Zeller, Jr., M.D., a former
surgical resident at Henry Ford
Hospital, passed away July 17,
2012 at the age of 88. Following his
residency, Dr. Zeller entered private
practice as a vascular surgeon for
more than 30 years. He then served
as medical director of Lake Wales
Medical Centers in Florida until
2001. Dr. Zeller was a member of
numerous medical societies and
organizations, including the Henry
Ford Medical Association. He
received his medical degree from
Indiana University and honorably
served as a captain in the U.S. Air
Force for two years, where he was
stationed in Korea and Japan. Dr.
Zeller is survived by Shirley, his
loving wife of 66 years, his daughter
and four grandchildren.
Henry Ford’s continued medical
innovations would not be possible
without our talented and energetic
workforce. In the future, we look
forward to continuing to bring you
the news on the latest achievements
and advancements at Henry Ford.
Best regards,
Lawrence C. Mitchell, M.D.
President
Henry Ford Medical Association
(Continued from Front Page)
• First in U.S. to implant donor vein
stents through a catheter to repair
leaking arteries.
• The only successful triple heart valve
repair through a catheter in pregnancy,
allowing the pregnancy to continue,
which open-heart surgery would not.
“Approximately one quarter of American
adults has some type of structural heart
defect,” says Dr. O’Neill. “Treating
structural heart disease with catheterbased techniques and less-invasive
surgeries is the next frontier in
cardiology.” 
For more information, visit
henryford.com/StructuralHeart.
A memorial donation is a special way to remember a friend or
colleague. Making a memorial gift in their honor can be a wonderful
tribute to their life, and may be designated to a specific department or
program at Henry Ford. For more information, call (313) 876-1031 or
visit henryford.com/giving.
7
ALUMNI NOTES
Niru Prasad, M.D., currently
working at Urgent Care in Livonia,
Mich., was invited as a visiting
physician to a local hospital in
Nairobi, Kenya. On February 23,
2013 she gave a lecture at the
hospital on the management
of children with burns in the
emergency room. Dr. Prasad can be
reached via email at niruprasad@
hotmail.com.
Elizabeth R. Ransom, M.D., FACS,
completed a residency in the
Department of Otolaryngology
from 1990-1994 at Henry Ford
Hospital and served as chair of the
Credentials Committee and vicechair of the Board of Governors
at Henry Ford until 2006. She was
recently appointed executive vice
president and clinical leader, North
Zone, for Texas Health Resources
(THR), and will be leading efforts
to redesign and improve care at
THR. Dr. Ransom can be reached
via email at elizabethransom@
texashealth.org.
8
Henry Ford Medical Group alumnus Dr. Hideaki Takahashi, recently
made the long trip from Japan to visit Henry Ford Hospital for the first
time in 50 years in celebration of the 50th anniversary of his graduation
from the Orthopaedic Surgery Residency Program. Following his residency,
Dr. Takahashi completed a research fellowship at Henry Ford Hospital
before returning to Japan to continue his medical career. Pictured from
left to right is Gary Gibson, Ph.D.; Theodore Parsons, M.D.; Hideaki
Takahashi, M.D., Ph.D.; and his wife, Dr. Takako Takahashi.
We want to hear from you!
henryford.com/alumni

Carl Bartecchi, M.D., MACP, was
a resident at Henry Ford Hospital.
Recently he published a book titled
The Bach Mai Hospital Project,
which details the improvements
made by the Vietnamese hospital
and the humanitarian projects
that made the improvements
possible. Dr. Bartecchi is currently
a Distinguished Clinical Professor
of Medicine at the University of
Colorado.
Anas Moureiden, M.D., a fellow in
the Department of Rheumatology
from 1993-1995 at Henry Ford
Hospital, currently works in a
private practice in Florida. Dr.
Moureiden can be reached via email
at [email protected].
The Alumni Notes section of Rounds
is a great way to share a professional
accomplishment, personal news or your
fondest Henry Ford memory. Send us
your update and your information may
appear in an upcoming issue. To send
your submission, visit henryford.com/
alumni. Updates may also be sent in
writing to:
Henry Ford Medical Association
Attn: Rounds Editor
1 Ford Place, 3B
Detroit, MI 48202-3450
OUTSTANDING RESIDENT AWARDS
On May 15, 2013, the Outstanding Residents Awards Banquet was held at the Detroit Athletic Club. This year 25
residents and fellows were recognized for their enthusiastic devotion to patient care, research and education. This year’s
winners include: Ariella Freidman, M.D., recipient of the Jan Rival Outstanding Resident Award; Brent Griffith, M.D.,
recipient of the Michael S. Benninger Outstanding Resident Award; Amanda Godfrey, M.D., recipient of the Roger F.
Smith Outstanding Resident Award; Joshua Collins, M.D., and Vivek Rai, M.D., recipients of the Peter Coggan Teaching
Award. Congratulations to all awardees and nominees!
Pictured are many of the 2013 winners and honorees (in alphabetical order): Victor Chang, M.D., Neurosurgery; Joshua
Collins, M.D., Internal Medicine; Jeffrey Devitt, M.D., Orthopaedic Surgery; Ariella Freidman, M.D., Urology; Khurshid
Ghani, M.D., Urology Minimally Invasive Surgery; Amanda Godfrey, M.D., Pulmonary Critical Care; Brent Griffith,
M.D., Diagnostic Radiology; Tamim Hamdi, M.D., Nephrology; Keiko Hendrick, M.D., Family Medicine; Gina Hurst,
M.D., Emergency Medicine/Internal Medicine; Anubhav Jagadish, M.D., Orthopaedic Surgery; Randa Jalloul, M.D.,
OB/GYN; Tarek Khalife, M.D., OB/GYN; Bassel Mahmoud, M.D., Dermatology; Neelima Nadella, M.D., Cardiology;
Keyur Patel, M.D., Neurology; Chirag Popat, M.D., Sleep Medicine; Alexis Raftopoulos, M.D., Anesthesiology; Vivek
Rai, M.D., Neurology; Jared Robbins, M.D., Radiation Oncology; Michael Romer, M.D., Anesthesiology; Sumit Singla,
M.D., Gastroenterology; Julian Suszanski, M.D., Emergency Medicine; Sandeep Walia, M.D., Internal Medicine; Hadeel
Zainah, M.D., Infectious Diseases.
9
CONGRATULATIONS TO THE 2013 GRADUATES!
Henry Ford Hospital trains more than 600 medical school students, 500 residents and 150 fellows across
46 different specialties every year. Our graduates have been exposed to a rich learning environment with
guidance and mentoring in a multidisciplinary setting by world-renowned faculty.
We are proud to recognize our 2013 program graduates:
Allergy
Mary Burnett, M.D.
Jennifer Rumpel, M.D.
Anesthesiology: Cardiothoracic
Maxime Madhere, M.D.
Anesthesiology: Pain Medicine
Adam Camp, M.D.
Sagar A. Patel, M.D.
Amir Samir, M.D.
Aman Upadhyaya, M.D.
Anesthesiology
Anjana Dwivedi, M.D.
Jennifer Henderson, D.O.
Thuan Le, M.D.
Carlos Montoya, M.D.
Michael Parks, M.D.
Paras Patel, M.D.
Georgeanne Raftopoulos, D.O.
Michael Romer, D.O.
Saida Saidova, M.D.
Kress Townley, M.D.
Cardiac Electrophysiology
Neelima Paladugu, M.D.
Parthiv Shah, M.D.
Cardiology
Tara Hrobowski, M.D.
Amrish Malhi, M.D.
Gurjit Singh, M.D.
Paul Vaitkus, M.D.
Dee Dee Wang, M.D.
Cardiology: Interventional
Antonious Attallah, M.D.
Joseph Chattahi, M.D.
Prasanth Lingam, M.D.
Critical Care Medicine
Julie John, M.D.
Dermatology
Julie Iwaski, M.D.
Bassel Mahmoud, M.D.
Viet Nguyen, M.D.
Frank Santoro, M.D.
Veena Vanchinathan, M.D.
Kara Walton, M.D.
10
Emergency Medicine
Bahareh Aslani, M.D.
Deborah Fadowole, M.D.
Monica Falconer, M.D.
Jennifer Hsieh, M.D.
Cameron Hypes, M.D.
Vinod Kumar, M.D.
Emily McLaren, M.D.
Thomas Mikulski, D.O.
Ankit Nanavati, M.D.
Mayura Phadtare, M.D.
Andre Porchia, M.D.
Julian Suszanski, M.D.
Ryan Worley, M.D.
Emergency Medicine & Internal
Medicine
Adam Schlichting, M.D.
Emergency Medicine: Ultrasound
John Gallien, M.D.
Endocrinology
Pendar Farahani, M.D.
Naveen Kakumanu, M.D.
Family Medicine
Onma Ameh, M.D.
Ahmid Dredar, M.D.
Keiko Anne Hendrick, M.D.
April Hom, M.D.
Elicia Jenkins-Brown, M.D.
Ronak Patel, M.D.
Israel Tellez Flores, M.D.
Gastroenterology
Eduardo Castillo del Castillo, M.D.
Robert Dempsey, M.D.
Humberto Gonzalez, M.D.
Rachel Schiesser, M.D.
General Surgery
Alfredo Cordova Dupreyrat, M.D.
Arika Peck, M.D.
Yekaterina Polyatskaya, M.D.
Brian Rosett, M.D.
Nathan Schmoekel, D.O.
Emily Smeltzer, M.D.
Hematology/Oncology
Mirna Farhat-Derwiche, M.D.
Steven Gamalski, M.D.
Mohamad Younes, M.D.
Hospice & Palliative Medicine
Rafi Ishaq, M.D.
Grace Pagaduan-Oddo, D.O.
Infectious Disease Transplantation
Marisa Miceli, M.D.
Infectious Disease
Edemekong Bassey, M.D.
Shubhita Bhatnagar, M.D.
Hadeel Zainah, M.D.
Internal Medicine
Mustafa Abas, M.D.
Raid Abu-Awwad, M.D.
Yathreb Alaai, M.D.
Ahmad Aldeiri, M.D.
Mohanad Alfaqih, M.D.
Mohammad Alhyari, M.D.
Mohammad Alqarqaz, M.D.
Nikhil Ambulgekar, M.D.
Mahmoud Assaad, M.D.
Joaquim Barboza, M.D.
Eduardo Bazan Lavanda, M.D.
Rafael Cabrera Salinas, M.D.
Juan Cattoni, M.D.
Surbhi Chamaria, M.D.
Aalok Dave, M.D.
Erics Esppinoza Moscoso, M.D.
Edgardo Flores Anticona, M.D.
Sami Hayek, M.D.
Jennifer Jorge, M.D.
Marilyn Karam, M.D.
Fatima Khalid, M.D.
Abdallah Kobeissy, M.D.
Michael Koniuch, M.D.
Ericka Li Fuentes, M.D.
George Maidaa, M.D.
Rosa Michel Ortega, M.D.
Karen Olarte- Merida, M.D.
Shital Patel, M.D.
Julio Pinto, M.D.
Waqas Qureshi, M.D.
Jatin Rana, M.D.
Snigdha Reddy, M.D.
Michael Rothberg, M.D.
Eiad Sabia, M.D.
Ahmad Saeed, M.D.
David Sanchez Vasquez, M.D.
Jessica Schering, M.D.
Sunay Shah, M.D.
Rushyal Shyamraj, M.D.
Hanish Singh, M.D.
Sandeep Walia, M.D.
George Yaghmour, M.D.
Mohammad Zaidan, M.D.
Otolaryngology
Brandon Musgrave, M.D.
William G. Young, M.D.
Nephrology Transplantation
Omar Saleh Abu-Romeh, M.D.
Pathology
David Nowak, M.D.
Linda Szymanski, D.O.
Ji Yoon Yoon, M.D.
Nephrology
Noori Al-Waili, M.D.
Hilana Hatoum, M.D.
Sayed M. Husain, M.D.
Adepeju Jinadu, M.D.
Felix Perez, M.D.
Jagannath Saikumar, M.D.
Josephus Sanjorjo, M.D.
Clinical Neurophysiology
Omar I. Ahmad, M.D.
Nawaf Murshed, M.D.
Neurology
Komal Ashraf, D.O.
Omran Kaskar, D.O.
Nelson Maldonado, M.D.
Sadia Najamuddin, D.O.
Keyur Patel, M.D.
Neurosurgery
Abbas Bahari, M.D.
Victor Chang, M.D.
Melvin Omodon, M.D.
Scott Phillips, M.D.
Obstetrics & Gynecology
Randa Jalloul, M.D.
Laleh Karimi, M.D.
Tarek Khalife, M.D.
Matthew Palmer, D.O.
Ophthalmology
David Chin Yee, M.D.
Christina Ryu, M.D.
Aly Sheraly, M.D.
Swapna Vemuri, M.D.
Asmaneh Yamagata, M.D.
Medical & Surgical Glaucoma
Amy Zhang, M.D.
Neuro-Ophthalmology
Poonam Bansal, M.D.
Neurology
Vivek Rai, M.D.
Orthopaedics
Kirk Cleland, M.D.
Jeffrey Devitt, M.D.
Heather Harrison, M.D.
Anubhav Jagadish, M.D.
Srinivasu Kusuma, M.D.
Orthopaedic Spine Medicine
Ritu Zacharias, M.D.
Cytopathology Fellow
Mohammad Shokouh-Amiri, M.D.
Pathology Informatics
Mehrvash Haghighi, M.D.
Psychiatry
Neha Gupta, M.D.
Melissa Hendriks, M.D.
Tiana Jarrahzadeh, D.O.
Abby Johnson, D.O.
Katie Keller, D.O.
Santosh Pillai, D.O.
Sarah Riehl, M.D.
Pulmonary: Critical Care
Christopher Butler, D.O.
Farooq Cheema, M.D.
Jennifer Gardner, M.D.
Amanda Godfrey, M.D.
Haitham Kanneh, M.D.
Mahmoud Mahafzah, M.D.
Sophia Mehboob, M.D.
Davorka Nikolic, M.D.
Veronica Ortiz, M.D.
Niraj Parikh, M.D.
Julio Pinto Corrales, M.D.
Akram Shibani, M.D.
Akintayo Sokunbi, M.D.
Dominik Starosta, M.D.
Ahmed Sulieman Daoud, M.D.
Interventional Pulmonology
Eduardo Celis Valdiviezo, M.D.
Haidong Huang, M.D.
Radiation Oncology
Jared Robbins, M.D.
Radiology
Peter Barkett, M.D.
Jeffrey Birn, M.D.
Chiraag Dharia, M.D.
Tashfeen Ekram, M.D.
Brent Griffith, M.D.
Ahmed Hafeez, M.D.
Farhaan Mir, M.D.
James Morrison, M.D.
Sailendra Sunkara, M.D.
Radiology: Body Imaging
Sherry Aujla, D.O.
Kanika Khanna, M.D.
Radiology: Breast Imaging
Jay Patel, M.D.
Radiology: Musculoskeletal
Paul Armour, M.D.
Randy Balmforth, M.D.
Sandra Lee, D.O.
Bisher Tarabishy, M.D.
Neuro-Radiology
Mohamad Saghir, M.D.
Gassan Shahin, M.D.
Bisher Taribishy, M.D.
Vascular Interventional Radiology
Ambreen Sattar, M.D.
Laurie Vance, M.D.
Radiology: Womens Imaging
Brandon Behjatnia, D.O.
Jessica Kaniowski, M.D.
Jenny Wang, D.O.
Sleep Medicine
Rami Abboud, M.D.
Niraj Parikh, M.D.
Chirag Popat, M.D.
Family Sports Medicine
Laura Owczarek, M.D.
Gonzalo Samitier Solis, M.D.
Colon & Rectal Surgery
Gie Na Yu, M.D.
Surgical Critical Care
Zachary Bauman, D.O.
Marika Gassner, D.O.
Transplant Surgery
Shunji Nagai, M.D.
Transitional Residency
Tammam Dayyoub, M.D.
Ryan Jaber, M.D.
Daniel Kim, M.D.
Cole Kreofsky, M.D.
Stefania Maraka, M.D.
Sumul Modi, M.D.
Daniel Montenegro, M.D.
Imama Naqvi, M.D.
Kushal Parikh, M.D.
Mihir Patel, M.D.
Robert Prinzi, M.D.
Swetha Renati, M.D.
Steven Saraf, M.D.
Prashant Thomas, M.D.
Sean Vance, M.D.
Urology: Clinical Research
Jay Jhaveri, M.D.
Fred Muhletaler, M.D.
Minimally Invasive Urologic Surgery
Wooju Jeong, M.D.
Quoc-Dien Trinh, M.D.
11
DETROIT, MI
PERMIT #6785
PAID
NON-PROFIT ORG
U.S. POSTAGE
CARDIAC SURGERY
Three-Star Rating:
Outcomes in Isolated CABG
Address Service Requested
1 Ford Place, 3B
Detroit, MI 48202
Henry Ford Medical Association
The Division of Cardiac Surgery at Henry Ford
Hospital and Henry Ford Macomb Hospital have
received a three-star rating from the Society
of Thoracic Surgeons (STS) for its outcomes in
isolated coronary artery bypass surgery (CABG).
Rounds is published by the Henry Ford Medical
Association for Henry Ford physicians, residents
and alumni.
Henry Ford Medical Association
Executive Committee:
Lawrence C. Mitchell, M.D., President
Lisa MacLean, M.D., Vice President
Jan Rival, M.D., Secretary
Dorothy Kahkonen, M.D., Treasurer
Eric Scher, M.D., Ex-Officio
Members at Large:
Mathilda Horst, M.D.
Lynn Miller, M.D.
Melissa Times, M.D.
Managing Editor:
Julie Perez
(313) 874-5000
henryford.com/alumni
Editorial Assistant:
Felicia Adamczyk
The STS CABG composite score is calculated
using a combination of 11 measures of quality,
divided into the following four broad categories:
1. Risk-adjusted mortality.
2. Risk-adjusted major morbidity—the
percentage of patients who leave the
Gaetano Paone, M.D.
hospital with none of the five most serious
complications of CABG—reoperation,
stroke, kidney failure, infection of the chest
wound, or prolonged need to be supported
by a breathing machine, or ventilator.
3. Percentage of CABG procedures that use at least one internal mammary (or
internal thoracic) artery for bypass grafting.
4. How often all of the four medications believed to improve a patient’s
immediate outcome and long-term risk of developing more blockages were
prescribed.
a. Aspirin and beta-blocking drugs prescribed pre-operatively.
b. Beta-blockers and cholesterol-lowering medicines prescribed postoperatively.
“It is very difficult to attain a three-star rating, so we’re obviously very pleased
that our considerable efforts at outcome improvement have been successful in
achieving this benchmark,” says Gaetano Paone, M.D., division head of Cardiac
Surgery. “However, we have more challenges to overcome, as it will be more
difficult to maintain this three-star rating, as even a single additional negative
outcome can be the difference between two and three stars. This is the reason
the majority of programs are rated two stars and only 10-12 percent of the
programs are at three stars.”
Each year, approximately 10 to 15 percent of all adult cardiac surgery database
participants have been rated three-star, the highest-quality rating, which
indicates a 99 percent statistical certainty that a participant’s performance is
above average.
The Society of Thoracic Surgeons Public Reporting Online lists participants’
scores for each of the four domains and the STS CABG overall composite score,
as well as a star rating. The report is available at www.sts.org. 